TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
2,358,921
|
2,161,066
|
1,222,165 |
Financial expenses |
95,378
|
79,520
|
7,814 |
Earnings before taxes |
-2,493,256
|
358,841
|
334,458 |
EBITDA |
750,260
|
701,645
|
369,351 |
Total assets |
10,967,773
|
13,732,861
|
14,127,287 |
Current assets |
1,285,585
|
1,051,131
|
1,022,784 |
Current liabilities |
374,123
|
414,973
|
693,920 |
Equity capital |
8,545,043
|
11,183,552
|
11,141,234 |
- share capital |
18,807
|
18,711
|
20,091 |
Employees (average) |
1,084
|
1,117
|
478 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
77.9%
|
81.4%
|
78.9% |
Turnover per employee |
2,176
|
1,935
|
2,557 |
Profit as a percentage of turnover |
-105.7%
|
16.6%
|
27.4% |
Return on assets (ROA) |
-21.9%
|
3.2%
|
2.4% |
Current ratio |
343.6%
|
253.3%
|
147.4% |
Return on equity (ROE) |
-29.2%
|
3.2%
|
3.0% |
Change turnover |
186,726
|
1,037,897
|
316,471 |
Change turnover % |
9%
|
92%
|
35% |
Chg. No. of employees |
-33
|
639
|
73 |
Chg. No. of employees % |
-3%
|
134%
|
18% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.